Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


6th Imaging in Drug Discovery & Development

08 May 2013 - 10 May 2013 - Boston, MA, USA



Bookmark and Share


GTC's 6th Imaging in Drug Discovery and Development conference, one of four parallel tracks of the 2nd Novel Technologies in Drug Discovery Summit on May 8-10, 2013 in Boston, MA, is the only imaging conference that brings together high-level/influential leaders with decision-making authority from the pharmaceutical industry, academia, and government to share their knowledge and expertise in drug discovery and development . Our approach offers a more intimate and networking-oriented environment that is geared towards connecting scientists and researchers who use single- and multimodal imaging applications to further collaborate and advance their imaging projects in drug discovery and development. 

Session topics include: 

Advantages and Challenges of Available Imaging Modalities

Translational Imaging Applications: Preclinical to Clinical 

Imaging Applications Across Multiple Therapeutic Areas 

Molecular Imaging and Diagnostic Approaches and Capabilities 

High Content Imaging, Quantitative Imaging and Modeling Capabilities

The conference will run parallel with the other exciting conferences:

8th Assay and Drug Discovery Technologies

7th Drug Design and Medicinal Chemistry

3rd Next Generation Sequencing

Orphan Drugs Research and Commercialization

Sign up for the summit pass and get access to all 5 tracks in the summit! Or register 3 attendees for the price of 2 by entering coupon code rcdvb when you sign up!

We look forward to seeing you at the 6th Imaging in Drug Discovery and Development Conference!

 



Further information
Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!